Keywords: dtc, rx, drug, advertising, reaches, billion, months
US DTC Rx drug advertising reaches $1.5 billion in 12 months through March
Article | 09 June 1999
US direct-to-consumer advertising of prescription drugs continues itsdouble-digit growth, rising 16% to $1.53 billion in the 12 months through March 1999, compared to 24% growth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
